Immunome, Inc. (IMNM)
22.46
+0.34
(+1.54%)
USD |
NASDAQ |
Feb 25, 10:33
Immunome Research and Development Expense (Quarterly) : 49.19M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Prelude Therapeutics, Inc. | 21.71M |
| Eli Lilly & Co. | 3.802B |
| Relay Therapeutics, Inc. | 68.26M |
| Context Therapeutics, Inc. | 8.722M |
| Moderna, Inc. | 708.00M |